SB 706504 is a potent p38 MAPK inhibitor that inhibits Lipopolysaccharides ( HY-D1056 )-stimulated inflammatory gene expression in macrophages in chronic obstructive pulmonary disease (COPD).
Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > MAPK/ERK Pathway | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > p38 MAPK
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.